Subsequently is has been shown that RAS mutations are rare events in BCR/ABL negative chronic myeloid leukemia (CML) but are prevalent in CMML (14). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.